Patents by Inventor Nicolas RIVOLTA

Nicolas RIVOLTA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220145447
    Abstract: A fractioning device for an ion implantation device with at least one fractioning wall, wherein the fractioning device is suitable for being inserted within a channel. The channel is configured to connect an ion source, which is at a first pressure p1 and a processing chamber, which is at a second pressure p2 in an ion implantation device.
    Type: Application
    Filed: February 25, 2020
    Publication date: May 12, 2022
    Applicants: AGC GLASS EUROPE, AGC INC., AGC FLAT GLASS NORTH AMERICA, INC., AGC VIDROS DO BRASIL LTDA
    Inventors: Philippe ROQUINY, José FERNANDES, Nicolas RIVOLTA, Benjamine NAVET, Amory JACQUES
  • Publication number: 20210108173
    Abstract: This invention relates to an improved method for generating otic progenitor cells. The invention also relates to uses of such otic progenitor cells, for example as a medicament (e.g. in the treatment of hearing loss, deafness or other auditory disorder associated with loss of inner ear function) and/or in drug screening methods.
    Type: Application
    Filed: October 21, 2020
    Publication date: April 15, 2021
    Applicant: THE UNIVERSITY OF SHEFFIELD
    Inventors: Carlos Marcelo Nicolas RIVOLTA, Darrell Michael BARROTT
  • Patent number: 10844351
    Abstract: This invention relates to an improved method for generating otic progenitor cells. The invention also relates to uses of such otic progenitor cells, for example as a medicament (e.g. in the treatment of hearing loss, deafness or other auditory disorder associated with loss of inner ear function) and/or in drug screening methods.
    Type: Grant
    Filed: March 30, 2016
    Date of Patent: November 24, 2020
    Assignee: The University of Sheffield
    Inventors: Carlos Marcelo Nicolas Rivolta, Darrell Michael Barrott
  • Publication number: 20190185813
    Abstract: The present invention relates generally to the identification and isolation of human otic progenitor cells. More specifically, the present invention relates to a method of using cell markers to identify and isolate human otic progenitor cells from a mixed population of cells, methods of enrichment and production of human otic progenitor cells, and associated kits for use in identification and/or isolation of human otic progenitor cells, wherein the cell markers are selected from SSEA1 (CD15), disialoganglioside GD3, TRA-2-49 (liver/bone/ kidney alkaline phosphatase), SSEA4, ganglioside GD2 and CD141.
    Type: Application
    Filed: September 14, 2017
    Publication date: June 20, 2019
    Applicant: THE UNIVERSITY OF SHEFFIELD
    Inventors: Carlos Marcelo Nicolas Rivolta, Sarah Louise Boddy
  • Publication number: 20180087026
    Abstract: This invention relates to an improved method for generating otic progenitor cells. The invention also relates to uses of such otic progenitor cells, for example as a medicament (e.g. in the treatment of hearing loss, deafness or other auditory disorder associated with loss of inner ear function) and/or in drug screening methods.
    Type: Application
    Filed: March 30, 2016
    Publication date: March 29, 2018
    Inventors: Carlos Marcelo Nicolas RIVOLTA, Darrell Michael BARROTT